HHS Secretary says several drug companies looking at ‘substantial’ price cuts

Wall Street Journal

12 June 2018 - Democrats say administration’s plan to lower drug prices will accomplish little.

Health and Human Services Secretary Alex Azar on Tuesday touted the administration’s plan to combat high drug prices, saying several drug companies are looking at “substantial and material” price cuts, while Democrats said the plan would accomplish little.

He said in testimony before the Senate health committee that companies are working with industry middlemen, including pharmacy-benefit managers, to make sure “they’re not discriminated against” for cutting their prices. Middlemen currently have an incentive to provide more favourable coverage to drugs with higher list prices, he said.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing